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Abstract：For patients with mental diseases, safe food-intake and the maintenance of good oral 
hygiene become difficult due to a decline in the ability of daily livings. In addition, a majority of 
patients suffer from the lack of reflection of both deglutition and cough as well as clinical silent 
aspiration, resulting from the extrapyramidal symptom (EPS) caused by antipsychotics.
　In this clinical study, we evaluated the oral environment in 10 inpatients with psychiatry neurology, 
and examined the usefulness of professional oral care. They were divided into 2 groups: the physical 
restriction group (restriction group) and the non-physical restriction group (control group), followed 
by the estimation of the conditions of oral hygiene and the days accompanied by fever, one of the 
symptoms of aspiration-related pneumonia, before and after professional oral care intervention.
　As a result, restriction group had poor oral hygiene condition as compared to the control group. 
After professional oral care intervention, oral hygiene condition was significantly improved in the 
restriction group, and reached to the same levels as in the control group. The days with fever were 
7.3 and 5.0 days per month in the restriction group before and after the intervention, respectively. In 
the control group, those were 0.6 and 0 day per month before and after intervention, respectively. The 
cause of the difference in days with fever between 2 groups was considered to be the effect of clinical 
silent aspiration by EPS induced by antipsychotics.
　The professional oral care contributed to the improvement of the oral hygiene in inpatients with 
psychiatry neurology, resulting in the reduction of aspiration-related pneumonia. Therefore, the role of 
dentistry in the field of psychiatry neurology would be inevitable in the future.
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